STBT5:Volunteer Assignments and Opportunities: Difference between revisions

From Compendium of Cancer Genome Aberrations
Jump to navigation Jump to search
[checked revision][checked revision]
← Older edit
VisualWikitext
No edit summary
No edit summary
 
(36 intermediate revisions by 4 users not shown)
Line 18: Line 18:
!'''Notes'''
!'''Notes'''
|-
|-
|CHAPTER 2 (SOFT TISSUE TUMOURS)
|
====CHAPTER 2 (SOFT TISSUE TUMOURS)====
|
|
----
----
Line 147: Line 148:
|
|
|
|
|-
|-
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|-
|[[STBT5:Atypical_lipomatous_tumour_/_well-differentiated_liposarcoma|Atypical lipomatous tumour / well-differentiated liposarcoma]]
|[[STBT5:Atypical_lipomatous_tumour_/_well-differentiated_liposarcoma|Atypical lipomatous tumour / well-differentiated liposarcoma]]
Line 215: Line 225:
|-
|-
|[[STBT5:Proliferative_fasciitis_and_proliferative_myositis|Proliferative fasciitis and proliferative myositis]]
|[[STBT5:Proliferative_fasciitis_and_proliferative_myositis|Proliferative fasciitis and proliferative myositis]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|12/8/2025
|Katie Schieffer
|12/8/2025
|Minimal genetic content added
|-
|[[STBT5:Myositis_ossificans_and_fibro-osseous_pseudotumour_of_digits|Myositis ossificans and fibro-osseous pseudotumour of digits]]
|Disease
|Disease
|
|
Line 225: Line 246:
|
|
|-
|-
|[[STBT5:Myositis_ossificans_and_fibro-osseous_pseudotumour_of_digits|Myositis ossificans and fibro-osseous pseudotumour of digits]]
|[[STBT5:Ischaemic_fasciitis|Ischaemic fasciitis]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|10/16/2025
|Katie Schieffer
|10/16/2025
|No genetic association
|-
|[[STBT5:Elastofibroma|Elastofibroma]]
|Disease
|Disease
|
|
Line 236: Line 268:
|
|
|-
|-
|[[STBT5:Ischaemic_fasciitis|Ischaemic fasciitis]]
|-
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[STBT5:Fibrous_hamartoma_of_infancy|Fibrous hamartoma of infancy]]
|Disease
|Disease
|
|
Line 247: Line 288:
|
|
|-
|-
|[[STBT5:Elastofibroma|Elastofibroma]]
|[[STBT5:Fibromatosis_colli|Fibromatosis colli]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|9/22/2025
|Katie Schieffer
|9/22/2025
|No genetic association
|-
|[[STBT5:Juvenile_hyaline_fibromatosis|Juvenile hyaline fibromatosis]]
|Disease
|Disease
|
|
Line 258: Line 310:
|
|
|-
|-
|[[STBT5:Fibrous_hamartoma_of_infancy|Fibrous hamartoma of infancy]]
|[[STBT5:Inclusion_body_fibromatosis|Inclusion body fibromatosis]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|10/16/2025
|Katie Schieffer
|10/16/2025
|No genetic association
|-
|[[STBT5:Fibroma_of_tendon_sheath|Fibroma of tendon sheath]]
|Disease
|Disease
|
|
Line 269: Line 332:
|
|
|-
|-
|[[STBT5:Fibromatosis_colli|Fibromatosis colli]]
|[[STBT5:Desmoplastic_fibroblastoma|Desmoplastic fibroblastoma]]
|Disease
|Disease
|
|
Line 280: Line 343:
|
|
|-
|-
|[[STBT5:Juvenile_hyaline_fibromatosis|Juvenile hyaline fibromatosis]]
|[[STBT5:Myofibroblastoma|Myofibroblastoma]]
|Disease
|Disease
|
|
Line 291: Line 354:
|
|
|-
|-
|[[STBT5:Inclusion_body_fibromatosis|Inclusion body fibromatosis]]
|[[STBT5:Calcifying_aponeurotic_fibroma|Calcifying aponeurotic fibroma]]
|Disease
|Disease
|
|
Line 302: Line 365:
|
|
|-
|-
|[[STBT5:Fibroma_of_tendon_sheath|Fibroma of tendon sheath]]
|[[STBT5:EWSR1-SMAD3-positive_fibroblastic_tumour_(emerging)|EWSR1-SMAD3-positive fibroblastic tumour (emerging)]]
|Disease
|Disease
|
|
Line 313: Line 376:
|
|
|-
|-
|[[STBT5:Desmoplastic_fibroblastoma|Desmoplastic fibroblastoma]]
|[[STBT5:Angiomyofibroblastoma|Angiomyofibroblastoma]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|10/21/2025
|Katie Schieffer
|10/21/2025
|
|-
|-
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[STBT5:Cellular_angiofibroma|Cellular angiofibroma]]
|Disease
|Disease
|
|
Line 324: Line 407:
|
|
|-
|-
|[[STBT5:Myofibroblastoma|Myofibroblastoma]]
|[[STBT5:Angiofibroma_of_soft_tissue|Angiofibroma of soft tissue]]
|Disease
|Disease
|
|
Line 335: Line 418:
|
|
|-
|-
|[[STBT5:Calcifying_aponeurotic_fibroma|Calcifying aponeurotic fibroma]]
|[[STBT5:Nuchal-type_fibroma|Nuchal-type fibroma]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|12/8/2025
|Katie Schieffer
|12/8/2025
|No genetic association
|-
|[[STBT5:Acral_fibromyxoma|Acral fibromyxoma]]
|Disease
|Disease
|
|
Line 346: Line 440:
|
|
|-
|-
|[[STBT5:EWSR1-SMAD3-positive_fibroblastic_tumour_(emerging)|EWSR1-SMAD3-positive fibroblastic tumour (emerging)]]
|[[STBT5:Gardner_fibroma|Gardner fibroma]]
|Disease
|Disease
|
|
Line 357: Line 451:
|
|
|-
|-
|[[STBT5:Angiomyofibroblastoma|Angiomyofibroblastoma]]
|[[STBT5:Palmar_fibromatosis_and_plantar_fibromatosis|Palmar fibromatosis and plantar fibromatosis]]
|Disease
|Kati
e Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|12/12/2025
|Katie Schieffer
|12/12/2025
|Minimal genetic content added
|-
|[[STBT5:Desmoid_fibromatosis|Desmoid fibromatosis]]
|Disease
|Disease
|
|
Line 368: Line 474:
|
|
|-
|-
|[[STBT5:Cellular_angiofibroma|Cellular angiofibroma]]
|[[STBT5:Lipofibromatosis|Lipofibromatosis]]
|Disease
|Disease
|
|
Line 379: Line 485:
|
|
|-
|-
|[[STBT5:Angiofibroma_of_soft_tissue|Angiofibroma of soft tissue]]
|[[STBT5:Giant_cell_fibroblastoma|Giant cell fibroblastoma]]
|Disease
|Disease
|
|
Line 390: Line 496:
|
|
|-
|-
|[[STBT5:Nuchal-type_fibroma|Nuchal-type fibroma]]
|[[STBT5:Dermatofibrosarcoma_protuberans|Dermatofibrosarcoma protuberans]]
|Disease
|Disease
|
|
Line 401: Line 507:
|
|
|-
|-
|[[STBT5:Acral_fibromyxoma|Acral fibromyxoma]]
|-
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[STBT5:Solitary_fibrous_tumour|Solitary fibrous tumour]]
|Disease
|Yiting Li (trainee);
Shashirekha Shetty (mentor)
|9/24/2025
|12/24/2025
|COMPLETE
|12/18/2025
|Katie Schieffer
|12/18/2025
|
|-
|[[STBT5:Inflammatory_myofibroblastic_tumour|Inflammatory myofibroblastic tumour]]
|Disease
|Disease
|
|
Line 412: Line 539:
|
|
|-
|-
|[[STBT5:Gardner_fibroma|Gardner fibroma]]
|[[STBT5:Low-grade_myofibroblastic_sarcoma|Low-grade myofibroblastic sarcoma]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|12/10/2025
|Katie Schieffer
|12/10/2025
|No genetic association
|-
|[[STBT5:Superficial_CD34-positive_fibroblastic_tumour|Superficial CD34-positive fibroblastic tumour]]
|Disease
|Disease
|
|
Line 423: Line 561:
|
|
|-
|-
|[[STBT5:Palmar_fibromatosis_and_plantar_fibromatosis|Palmar fibromatosis and plantar fibromatosis]]
|[[STBT5:Myxoinflammatory_fibroblastic_sarcoma|Myxoinflammatory fibroblastic sarcoma]]
|Disease
|Disease
|Mokhtar Abdelhammed, MD (trainee);
Katie Schieffer (mentor)
|3/1/2026
|6/30/2026
|PENDING
|
|
|
|
|
|
|
|
|
|-
|
|[[STBT5:Infantile_fibrosarcoma|Infantile fibrosarcoma]]
|
|Disease
|Katie Schieffer
|4/21/2025
|10/1/2025
|COMPLETE
|9/18/2025
|Katie Schieffer
|9/18/2025
|
|
|-
|-
|[[STBT5:Desmoid_fibromatosis|Desmoid fibromatosis]]
|[[STBT5:Adult_fibrosarcoma|Adult fibrosarcoma]]
|Disease
|Disease
|
|
Line 445: Line 595:
|
|
|-
|-
|[[STBT5:Lipofibromatosis|Lipofibromatosis]]
|[[STBT5:Myxofibrosarcoma|Myxofibrosarcoma]]
|Disease
|Disease
|
|
Line 456: Line 606:
|
|
|-
|-
|[[STBT5:Giant_cell_fibroblastoma|Giant cell fibroblastoma]]
|[[STBT5:Low-grade_fibromyxoid_sarcoma|Low-grade fibromyxoid sarcoma]]
|Disease
|Disease
|
|
Line 467: Line 617:
|
|
|-
|-
|[[STBT5:Dermatofibrosarcoma_protuberans|Dermatofibrosarcoma protuberans]]
|[[STBT5:Sclerosing_epithelioid_fibrosarcoma|Sclerosing epithelioid fibrosarcoma]]
|Disease
|Disease
|
|
Line 478: Line 628:
|
|
|-
|-
|[[STBT5:Solitary_fibrous_tumour|Solitary fibrous tumour]]
|Disease
|Shashi Shetty and Reba Daniel (resident)
|2/21/2024
|
|PENDING
|
|Katherine Geiersbach
|
|Template added 2/21/2024
|-
|-
|[[STBT5:Inflammatory_myofibroblastic_tumour|Inflammatory myofibroblastic tumour]]
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[STBT5:Tenosynovial_giant_cell_tumour|Tenosynovial giant cell tumour]]
|Disease
|Disease
|
|
Line 500: Line 648:
|
|
|-
|-
|[[STBT5:Low-grade_myofibroblastic_sarcoma|Low-grade myofibroblastic sarcoma]]
|[[STBT5:Deep_fibrous_histiocytoma|Deep fibrous histiocytoma]]
|Disease
|Disease
|
|
Line 511: Line 659:
|
|
|-
|-
|[[STBT5:Superficial_CD34-positive_fibroblastic_tumour|Superficial CD34-positive fibroblastic tumour]]
|[[STBT5:Plexiform_fibrohistiocytic_tumour|Plexiform fibrohistiocytic tumour]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|12/8/2025
|Katie Schieffer
|12/8/2025
|No genetic association
|-
|[[STBT5:Giant_cell_tumour_of_soft_tissue|Giant cell tumour of soft tissue]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|12/10/2025
|Katie Schieffer
|12/10/2025
|No genetic association
|-
|[[STBT5:Synovial_haemangioma|Synovial haemangioma]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|11/10/2025
|Katie Schieffer
|11/10/2025
|No genetic association
|-
|[[STBT5:Intramuscular_angioma|Intramuscular angioma]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|12/10/2025
|Katie Schieffer
|12/10/2025
|No genetic association
|-
|[[STBT5:Arteriovenous_malformation/haemangioma|Arteriovenous malformation/haemangioma]]
|Disease
|Disease
|
|
Line 522: Line 714:
|
|
|-
|-
|[[STBT5:Myxoinflammatory_fibroblastic_sarcoma|Myxoinflammatory fibroblastic sarcoma]]
|[[STBT5:Venous_haemangioma|Venous haemangioma]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|12/10/2025
|Katie Schieffer
|12/10/2025
|No genetic association
|-
|[[STBT5:Anastomosing_haemangioma|Anastomosing haemangioma]]
|Disease
|Disease
|
|
Line 533: Line 736:
|
|
|-
|-
|[[STBT5:Infantile_fibrosarcoma|Infantile fibrosarcoma]]
|[[STBT5:Epithelioid_haemangioma|Epithelioid haemangioma]]
|Disease
|Disease
|
|
Line 544: Line 747:
|
|
|-
|-
|[[STBT5:Adult_fibrosarcoma|Adult fibrosarcoma]]
|-
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[STBT5:Lymphangioma_and_lymphangiomatosis|Lymphangioma and lymphangiomatosis]]
|Disease
|Disease
|
|
Line 555: Line 767:
|
|
|-
|-
|[[STBT5:Myxofibrosarcoma|Myxofibrosarcoma]]
|[[STBT5:Tufted_angioma_and_kaposiform_haemangioendothelioma|Tufted angioma and kaposiform haemangioendothelioma]]
|Disease
|Disease
|
|
Line 566: Line 778:
|
|
|-
|-
|[[STBT5:Low-grade_fibromyxoid_sarcoma|Low-grade fibromyxoid sarcoma]]
|[[STBT5:Retiform_haemangioendothelioma|Retiform haemangioendothelioma]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|12/11/2025
|Katie Schieffer
|12/11/2025
|Minimal genetic content added
|-
|[[STBT5:Papillary_intralymphatic_angioendothelioma|Papillary intralymphatic angioendothelioma]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|12/11/2025
|Katie Schieffer
|12/11/2025
|Minimal genetic content added
|-
|[[STBT5:Composite_haemangioendothelioma_|Composite haemangioendothelioma]]
|Disease
|Disease
|
|
Line 577: Line 811:
|
|
|-
|-
|[[STBT5:Sclerosing_epithelioid_fibrosarcoma|Sclerosing epithelioid fibrosarcoma]]
|[[STBT5:Kaposi_sarcoma|Kaposi sarcoma]]
|Disease
|Disease
|
|
Line 588: Line 822:
|
|
|-
|-
|[[STBT5:Tenosynovial_giant_cell_tumour|Tenosynovial giant cell tumour]]
|[[STBT5:Pseudomyogenic_haemangioendothelioma|Pseudomyogenic haemangioendothelioma]]
|Disease
|Disease
|
|
Line 599: Line 833:
|
|
|-
|-
|[[STBT5:Deep_fibrous_histiocytoma|Deep fibrous histiocytoma]]
|[[STBT5:Epithelioid_haemangioendothelioma|Epithelioid haemangioendothelioma]]
|Disease
|Disease
|
|
Line 610: Line 844:
|
|
|-
|-
|[[STBT5:Plexiform_fibrohistiocytic_tumour|Plexiform fibrohistiocytic tumour]]
|[[STBT5:Angiosarcoma|Angiosarcoma]]
|Disease
|Disease
|
|
Line 621: Line 855:
|
|
|-
|-
|[[STBT5:Giant_cell_tumour_of_soft_tissue|Giant cell tumour of soft tissue]]
|[[STBT5:Glomus_tumour|Glomus tumour]]
|Disease
|Disease
|
|
Line 632: Line 866:
|
|
|-
|-
|[[STBT5:Synovial_haemangioma|Synovial haemangioma]]
|-
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[STBT5:Myopericytoma,_including_myofibroma|Myopericytoma, including myofibroma]]
|Disease
|Disease
|
|
Line 643: Line 886:
|
|
|-
|-
|[[STBT5:Intramuscular_angioma|Intramuscular angioma]]
|[[STBT5:Angioleiomyoma|Angioleiomyoma]]
|Disease
|Disease
|
|
Line 654: Line 897:
|
|
|-
|-
|[[STBT5:Arteriovenous_malformation/haemangioma|Arteriovenous malformation/haemangioma]]
|[[STBT5:Leiomyoma|Leiomyoma]]
|Disease
|Disease
|
|
Line 665: Line 908:
|
|
|-
|-
|[[STBT5:Venous_haemangioma|Venous haemangioma]]
|[[STBT5:EBV-associated_smooth_muscle_tumour|EBV-associated smooth muscle tumour]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|12/12/2025
|Katie Schieffer
|12/12/2025
|No genetic association
|-
|[[STBT5:Inflammatory_leiomyosarcoma|Inflammatory leiomyosarcoma]]
|Disease
|Disease
|
|
Line 676: Line 930:
|
|
|-
|-
|[[STBT5:Anastomosing_haemangioma|Anastomosing haemangioma]]
|[[STBT5:Leiomyosarcoma|Leiomyosarcoma]]
|Disease
|Disease
|
|
Line 687: Line 941:
|
|
|-
|-
|[[STBT5:Epithelioid_haemangioma|Epithelioid haemangioma]]
|[[STBT5:Rhabdomyoma|Rhabdomyoma]]
|Disease
|Disease
|
|
Line 698: Line 952:
|
|
|-
|-
|[[STBT5:Lymphangioma_and_lymphangiomatosis|Lymphangioma and lymphangiomatosis]]
|[[STBT5:Embryonal_rhabdomyosarcoma|Embryonal rhabdomyosarcoma]]
|Disease
|Disease
|
|
Line 709: Line 963:
|
|
|-
|-
|[[STBT5:Tufted_angioma_and_kaposiform_haemangioendothelioma|Tufted angioma and kaposiform haemangioendothelioma]]
|[[STBT5:Alveolar_rhabdomyosarcoma|Alveolar rhabdomyosarcoma]]
|Disease
|Disease
|
|
Line 720: Line 974:
|
|
|-
|-
|[[STBT5:Retiform_haemangioendothelioma|Retiform haemangioendothelioma]]
|[[STBT5:Pleomorphic_rhabdomyosarcoma|Pleomorphic rhabdomyosarcoma]]
|Disease
|Disease
|
|
Line 731: Line 985:
|
|
|-
|-
|[[STBT5:Papillary_intralymphatic_angioendothelioma|Papillary intralymphatic angioendothelioma]]
|-
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[STBT5:Spindle_cell_/_sclerosing_rhabdomyosarcoma|Spindle cell / sclerosing rhabdomyosarcoma]]
|Disease
|Disease
|
|
Line 742: Line 1,005:
|
|
|-
|-
|[[STBT5:Composite_haemangioendothelioma_|Composite haemangioendothelioma]]
|[[STBT5:Ectomesenchymoma|Ectomesenchymoma]]
|Disease
|Disease
|
|
Line 753: Line 1,016:
|
|
|-
|-
|[[STBT5:Kaposi_sarcoma|Kaposi sarcoma]]
|[[STBT5:Gastrointestinal_stromal_tumour|Gastrointestinal stromal tumour]]
|Disease
|Disease
|
|
Line 764: Line 1,027:
|
|
|-
|-
|[[STBT5:Pseudomyogenic_haemangioendothelioma|Pseudomyogenic haemangioendothelioma]]
|[[STBT5:Soft_tissue_chondroma|Soft tissue chondroma]]
|Disease
|Disease
|
|
Line 775: Line 1,038:
|
|
|-
|-
|[[STBT5:Epithelioid_haemangioendothelioma|Epithelioid haemangioendothelioma]]
|[[STBT5:Extraskeletal_osteosarcoma|Extraskeletal osteosarcoma]]
|Disease
|Disease
|
|
Line 786: Line 1,049:
|
|
|-
|-
|[[STBT5:Angiosarcoma|Angiosarcoma]]
|[[STBT5:Schwannoma|Schwannoma]]
|Disease
|Disease
|
|
Line 797: Line 1,060:
|
|
|-
|-
|[[STBT5:Glomus_tumour|Glomus tumour]]
|[[STBT5:Neurofibroma|Neurofibroma]]
|Disease
|Disease
|
|
Line 808: Line 1,071:
|
|
|-
|-
|[[STBT5:Myopericytoma,_including_myofibroma|Myopericytoma, including myofibroma]]
|[[STBT5:Perineurioma|Perineurioma]]
|Disease
|Disease
|
|
Line 819: Line 1,082:
|
|
|-
|-
|[[STBT5:Angioleiomyoma|Angioleiomyoma]]
|[[STBT5:Granular_cell_tumour|Granular cell tumour]]
|Disease
|Disease
|
|
Line 830: Line 1,093:
|
|
|-
|-
|[[STBT5:Leiomyoma|Leiomyoma]]
|[[STBT5:Dermal_nerve_sheath_myxoma|Dermal nerve sheath myxoma]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|12/11/2025
|Katie Schieffer
|12/11/2025
|No genetic association
|-
|-
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[STBT5:Solitary_circumscribed_neuroma|Solitary circumscribed neuroma]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|12/11/2025
|Katie Schieffer
|12/11/2025
|No genetic association
|-
|[[STBT5:Ectopic_meningioma_and_meningothelial_hamartoma|Ectopic meningioma and meningothelial hamartoma]]
|Disease
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|PENDING
|
|
|
|Consider linking to CNS tumor book
|-
|[[STBT5:Benign_triton_tumour_/_neuromuscular_choristoma|Benign triton tumour / neuromuscular choristoma]]
|Disease
|
|
|
|
|
|
|
|
|
|
|
|
Line 841: Line 1,146:
|
|
|-
|-
|[[STBT5:EBV-associated_smooth_muscle_tumour|EBV-associated smooth muscle tumour]]
|[[STBT5:Hybrid_nerve_sheath_tumour|Hybrid nerve sheath tumour]]
|Disease
|Disease
|
|
Line 852: Line 1,157:
|
|
|-
|-
|[[STBT5:Inflammatory_leiomyosarcoma|Inflammatory leiomyosarcoma]]
|[[STBT5:Malignant_peripheral_nerve_sheath_tumour|Malignant peripheral nerve sheath tumour]]
|Disease
|Disease
|
|
Line 863: Line 1,168:
|
|
|-
|-
|[[STBT5:Leiomyosarcoma|Leiomyosarcoma]]
|[[STBT5:Malignant_melanotic_nerve_sheath_tumour|Malignant melanotic nerve sheath tumour]]
|Disease
|Disease
|
|
Line 874: Line 1,179:
|
|
|-
|-
|[[STBT5:Rhabdomyoma|Rhabdomyoma]]
|[[STBT5:Intramuscular_myxoma|Intramuscular myxoma]]
|Disease
|Disease
|
|
Line 885: Line 1,190:
|
|
|-
|-
|[[STBT5:Embryonal_rhabdomyosarcoma|Embryonal rhabdomyosarcoma]]
|[[STBT5:Juxta-articular_myxoma|Juxta-articular myxoma]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|12/12/2025
|Katie Schieffer
|12/12/2025
|No genetic association
|-
|[[STBT5:Deep_(aggressive)_angiomyxoma|Deep (aggressive) angiomyxoma]]
|Disease
|Disease
|
|
Line 896: Line 1,212:
|
|
|-
|-
|[[STBT5:Alveolar_rhabdomyosarcoma|Alveolar rhabdomyosarcoma]]
|[[STBT5:Atypical_fibroxanthoma|Atypical fibroxanthoma]]
|Disease
|Disease
|
|
Line 907: Line 1,223:
|
|
|-
|-
|[[STBT5:Pleomorphic_rhabdomyosarcoma|Pleomorphic rhabdomyosarcoma]]
|-
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[STBT5:Angiomatoid_fibrous_histiocytoma|Angiomatoid fibrous histiocytoma]]
|Disease
|Disease
|
|
Line 918: Line 1,243:
|
|
|-
|-
|[[STBT5:Spindle_cell_/_sclerosing_rhabdomyosarcoma|Spindle cell / sclerosing rhabdomyosarcoma]]
|[[STBT5:Ossifying_fibromyxoid_tumour|Ossifying fibromyxoid tumour]]
|Disease
|Disease
|
|
Line 929: Line 1,254:
|
|
|-
|-
|[[STBT5:Ectomesenchymoma|Ectomesenchymoma]]
|[[STBT5:Myoepithelioma,_myoepithelial_carcinoma,_and_mixed_tumour|Myoepithelioma, myoepithelial carcinoma, and mixed tumour]]
|Disease
|Disease
|
|
Line 940: Line 1,265:
|
|
|-
|-
|[[STBT5:Gastrointestinal_stromal_tumour|Gastrointestinal stromal tumour]]
|[[STBT5:Pleomorphic_hyalinizing_angiectatic_tumour_of_soft_parts|Pleomorphic hyalinizing angiectatic tumour of soft parts]]
|Disease
|Disease
|Mokhtar Abdelhammed, MD (trainee);
Katie Schieffer (mentor)
|9/11/2025
|12/11/2025
|COMPLETE
|12/29/2026
|Katie Schieffer
|1/7/2026
|
|
|-
|[[STBT5:Haemosiderotic_fibrolipomatous_tumour|Haemosiderotic fibrolipomatous tumour]]
|Disease
|Mokhtar Abdelhammed, MD (trainee);
Katie Schieffer (mentor)
|3/1/2026
|6/30/2026
|PENDING
|
|
|
|
|
|
|
|
|-
|[[STBT5:Phosphaturic_mesenchymal_tumour|Phosphaturic mesenchymal tumour]]
|Disease
|
|
|
|
|
|
|-
|[[STBT5:Soft_tissue_chondroma|Soft tissue chondroma]]
|Disease
|
|
|
|
Line 958: Line 1,299:
|
|
|
|
|-
|[[STBT5:NTRK-rearranged_spindle_cell_neoplasm_(emerging)|NTRK-rearranged spindle cell neoplasm (emerging)]]
|Disease
|James Solomon, MD, PhD
|2/20/2022
|12/9/2025
|PENDING
|
|
|Katie Schieffer
|
|
|
|
|-
|-
|[[STBT5:Extraskeletal_osteosarcoma|Extraskeletal osteosarcoma]]
|[[STBT5:Synovial_sarcoma|Synovial sarcoma]]
|Disease
|Disease
|
|
Line 973: Line 1,322:
|
|
|-
|-
|[[STBT5:Schwannoma|Schwannoma]]
|[[STBT5:Epithelioid_sarcoma|Epithelioid sarcoma]]
|Disease
|Disease
|
|
Line 984: Line 1,333:
|
|
|-
|-
|[[STBT5:Neurofibroma|Neurofibroma]]
|[[STBT5:Alveolar_soft_part_sarcoma|Alveolar soft part sarcoma]]
|Disease
|Maxine Sutcliffe, PhD
|10/13/2025
|12/31/2025
|COMPLETE
|12/24/2025
|Katie Schieffer
|12/24/2025
|
|-
|[[STBT5:Clear_cell_sarcoma_of_soft_tissue|Clear cell sarcoma of soft tissue]]
|Disease
|Disease
|
|
Line 995: Line 1,355:
|
|
|-
|-
|[[STBT5:Perineurioma|Perineurioma]]
|-
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[STBT5:Extraskeletal_myxoid_chondrosarcoma_|Extraskeletal myxoid chondrosarcoma]]
|Disease
|Disease
|
|
Line 1,006: Line 1,375:
|
|
|-
|-
|[[STBT5:Granular_cell_tumour|Granular cell tumour]]
|[[STBT5:Desmoplastic_small_round_cell_tumour|Desmoplastic small round cell tumour]]
|Disease
|Disease
|
|Maxine Sutcliffe, PhD
|
|1/12/2026
|
|4/12/2026
|
|PENDING
|
|
|
|
Line 1,017: Line 1,386:
|
|
|-
|-
|[[STBT5:Dermal_nerve_sheath_myxoma|Dermal nerve sheath myxoma]]
|[[STBT5:Extrarenal_rhabdoid_tumour|Extrarenal rhabdoid tumour]]
|Disease
|Disease
|
|
Line 1,028: Line 1,397:
|
|
|-
|-
|[[STBT5:Solitary_circumscribed_neuroma|Solitary circumscribed neuroma]]
|[[STBT5:PEComa|PEComa]]
|Disease
|Disease
|
|
Line 1,039: Line 1,408:
|
|
|-
|-
|[[STBT5:Ectopic_meningioma_and_meningothelial_hamartoma|Ectopic meningioma and meningothelial hamartoma]]
|[[STBT5:Intimal_sarcoma|Intimal sarcoma]]
|Disease
|Disease
|
|
Line 1,050: Line 1,419:
|
|
|-
|-
|[[STBT5:Benign_triton_tumour_/_neuromuscular_choristoma|Benign triton tumour / neuromuscular choristoma]]
|[[STBT5:Undifferentiated_sarcoma|Undifferentiated sarcoma]]
|Disease
|Disease
|
|
Line 1,061: Line 1,430:
|
|
|-
|-
|[[STBT5:Hybrid_nerve_sheath_tumour|Hybrid nerve sheath tumour]]
|Disease
|
|
====CHAPTER 3 (UNDIFFERENTIATED SMALL ROUND CELL SARCOMAS OF BONE AND SOFT TISSUE)====
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
|-
----
|[[STBT5:Malignant_peripheral_nerve_sheath_tumour|Malignant peripheral nerve sheath tumour]]
|
----
|-
|[[STBT5:Ewing_sarcoma|Ewing sarcoma]]
|Disease
|Disease
|Sadeem Qdaisat (trainee); Eric McGinnis (mentor)
|10/1/2023
|12/9/2025
|PENDING
|
|
|
|Katie Schieffer
|
|
|
|
|
|
|
|
|-
|-
|[[STBT5:Malignant_melanotic_nerve_sheath_tumour|Malignant melanotic nerve sheath tumour]]
|[[STBT5:Round_cell_sarcoma_with_EWSR1-non-ETS_fusions|Round cell sarcoma with EWSR1-non-ETS fusions]]
|Disease
|Disease
|
|
Line 1,094: Line 1,473:
|
|
|-
|-
|[[STBT5:Intramuscular_myxoma|Intramuscular myxoma]]
|[[STBT5:CIC-rearranged_sarcoma|CIC-rearranged sarcoma]]
|Disease
|Disease
|
|
Line 1,105: Line 1,484:
|
|
|-
|-
|[[STBT5:Juxta-articular_myxoma|Juxta-articular myxoma]]
|[[STBT5:Sarcoma_with_BCOR_genetic_alterations|Sarcoma with BCOR genetic alterations]]
|Disease
|Disease
|
|
Line 1,116: Line 1,495:
|
|
|-
|-
|[[STBT5:Deep_(aggressive)_angiomyxoma|Deep (aggressive) angiomyxoma]]
|-
|Disease
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|
|
====CHAPTER 4 (BONE TUMOURS)====
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
----
|
----
|-
|[[STBT5:Subungual_exostosis|Subungual exostosis]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|12/12/2025
|Katie Schieffer
|12/12/2025
|No genetic association
|-
|-
|[[STBT5:Atypical_fibroxanthoma|Atypical fibroxanthoma]]
|[[STBT5:Bizarre_parosteal_osteochondromatous_proliferation|Bizarre parosteal osteochondromatous proliferation]]
|Disease
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|12/8/2025
|Katie Schieffer
|12/8/2025
|
|
|-
|[[STBT5:Periosteal_chondroma|Periosteal chondroma]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|PENDING
|
|
|
|
|
|
|
|-
|[[STBT5:Enchondroma|Enchondroma]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|PENDING
|
|
|
|
Line 1,138: Line 1,569:
|
|
|-
|-
|[[STBT5:Angiomatoid_fibrous_histiocytoma|Angiomatoid fibrous histiocytoma]]
|[[STBT5:Osteochondroma|Osteochondroma]]
|Disease
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|PENDING
|
|
|
|
|
|
|
|
|
|-
|
|[[STBT5:Chondroblastoma|Chondroblastoma]]
|
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|11/14/2025
|Katie Schieffer
|11/14/2025
|
|
|-
|-
|[[STBT5:Ossifying_fibromyxoid_tumour|Ossifying fibromyxoid tumour]]
|[[STBT5:Chondromyxoid_fibroma|Chondromyxoid fibroma]]
|Disease
|Disease
|
|
Line 1,160: Line 1,602:
|
|
|-
|-
|[[STBT5:Myoepithelioma,_myoepithelial_carcinoma,_and_mixed_tumour|Myoepithelioma, myoepithelial carcinoma, and mixed tumour]]
|[[STBT5:Osteochondromyxoma|Osteochondromyxoma]]
|Disease
|Disease
|
|
Line 1,171: Line 1,613:
|
|
|-
|-
|[[STBT5:Pleomorphic_hyalinizing_angiectatic_tumour_of_soft_parts|Pleomorphic hyalinizing angiectatic tumour of soft parts]]
|[[STBT5:Synovial_chondromatosis|Synovial chondromatosis]]
|Disease
|Disease
|
|
Line 1,182: Line 1,624:
|
|
|-
|-
|[[STBT5:Haemosiderotic_fibrolipomatous_tumour|Haemosiderotic fibrolipomatous tumour]]
|[[STBT5:Central_atypical_cartilaginous_tumour_/_chondrosarcoma,_grade_1|Central atypical cartilaginous tumour / chondrosarcoma, grade 1]]
|Disease
|Katie Schieffer
|9/21/2025
|12/31/2025
|COMPLETE
|11/14/2025
|Katie Schieffer
|11/14/2025
|
|-
|[[STBT5:Secondary_peripheral_atypical_cartilaginous_tumour_/_chondrosarcoma,_grade_1|Secondary peripheral atypical cartilaginous tumour / chondrosarcoma, grade 1]]
|Disease
|Disease
|
|
Line 1,193: Line 1,646:
|
|
|-
|-
|[[STBT5:Phosphaturic_mesenchymal_tumour|Phosphaturic mesenchymal tumour]]
|-
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[STBT5:Central_chondrosarcoma,_grades_2_and_3|Central chondrosarcoma, grades 2 and 3]]
|Disease
|Disease
|
|
Line 1,204: Line 1,666:
|
|
|-
|-
|[[STBT5:NTRK-rearranged_spindle_cell_neoplasm_(emerging)|NTRK-rearranged spindle cell neoplasm (emerging)]]
|[[STBT5:Secondary_peripheral_chondrosarcoma,_grades_2_and_3|Secondary peripheral chondrosarcoma, grades 2 and 3]]
|Disease
|Disease
|James Solomon, MD, PhD
|2/20/2022
|
|
|PENDING
|
|
|Alanna Church
|
|
|
|
|
|
|
|
|-
|-
|[[STBT5:Synovial_sarcoma|Synovial sarcoma]]
|[[STBT5:Periosteal_chondrosarcoma|Periosteal chondrosarcoma]]
|Disease
|Disease
|
|
Line 1,226: Line 1,688:
|
|
|-
|-
|[[STBT5:Epithelioid_sarcoma|Epithelioid sarcoma]]
|[[STBT5:Clear_cell_chondrosarcoma|Clear cell chondrosarcoma]]
|Disease
|Disease
|
|
Line 1,237: Line 1,699:
|
|
|-
|-
|[[STBT5:Alveolar_soft_part_sarcoma|Alveolar soft part sarcoma]]
|[[STBT5:Mesenchymal_chondrosarcoma|Mesenchymal chondrosarcoma]]
|Disease
|Disease
|
|
Line 1,248: Line 1,710:
|
|
|-
|-
|[[STBT5:Clear_cell_sarcoma_of_soft_tissue|Clear cell sarcoma of soft tissue]]
|[[STBT5:Dedifferentiated_chondrosarcoma_|Dedifferentiated chondrosarcoma]]
|Disease
|Disease
|
|
Line 1,259: Line 1,721:
|
|
|-
|-
|[[STBT5:Extraskeletal_myxoid_chondrosarcoma_|Extraskeletal myxoid chondrosarcoma]]
|[[STBT5:Osteoma|Osteoma]]
|Disease
|Disease
|
|
Line 1,270: Line 1,732:
|
|
|-
|-
|[[STBT5:Desmoplastic_small_round_cell_tumour|Desmoplastic small round cell tumour]]
|[[STBT5:Osteoid_osteoma_|Osteoid osteoma]]
|Disease
|Disease
|
|
Line 1,281: Line 1,743:
|
|
|-
|-
|[[STBT5:Extrarenal_rhabdoid_tumour|Extrarenal rhabdoid tumour]]
|[[STBT5:Osteoblastoma_|Osteoblastoma]]
|Disease
|Disease
|
|
Line 1,292: Line 1,754:
|
|
|-
|-
|[[STBT5:PEComa|PEComa]]
|[[STBT5:Low-grade_central_osteosarcoma|Low-grade central osteosarcoma]]
|Disease
|Disease
|
|
Line 1,303: Line 1,765:
|
|
|-
|-
|[[STBT5:Intimal_sarcoma|Intimal sarcoma]]
|-
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[STBT5:Osteosarcoma|Osteosarcoma]]
|Disease
|Fang Fang (trainee); Katie Schieffer (mentor)
|11/19/2025
|2/15/2026
|PENDING
|
|Katie Schieffer
|
|
|-
|[[STBT5:Parosteal_osteosarcoma_|Parosteal osteosarcoma]]
|Disease
|Disease
|
|
Line 1,314: Line 1,796:
|
|
|-
|-
|[[STBT5:Undifferentiated_sarcoma|Undifferentiated sarcoma]]
|[[STBT5:Periosteal_osteosarcoma_|Periosteal osteosarcoma]]
|Disease
|Disease
|
|
Line 1,325: Line 1,807:
|
|
|-
|-
|CHAPTER 3 (UNDIFFERENTIATED SMALL ROUND CELL SARCOMAS OF BONE AND SOFT TISSUE)
|[[STBT5:High-grade_surface_osteosarcoma|High-grade surface osteosarcoma]]
|Disease
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
----
|
|
----
|
|
----
|
|
----
|-
|-
|[[STBT5:Ewing_sarcoma|Ewing sarcoma]]
|[[STBT5:Secondary_osteosarcoma|Secondary osteosarcoma]]
|Disease
|Disease
|Sadeem Qdaisat
|10/1/23
|
|
|PENDING
|
|
|Working with Eric McGinnis
|
|
|2021 template added
|
|
|
|
|
|-
|-
|[[STBT5:Round_cell_sarcoma_with_EWSR1-non-ETS_fusions|Round cell sarcoma with EWSR1-non-ETS fusions]]
|[[STBT5:Desmoplastic_fibroma_of_bone|Desmoplastic fibroma of bone]]
|Disease
|Disease
|
|
Line 1,367: Line 1,840:
|
|
|-
|-
|[[STBT5:CIC-rearranged_sarcoma|CIC-rearranged sarcoma]]
|[[STBT5:Fibrosarcoma_of_bone|Fibrosarcoma of bone]]
|Disease
|Disease
|Ganesh Pandurang, MD
|2/28/24
|
|
|PENDING
|
|
|Katherine Geiersbach
|
|
|
|
|
|
|
|
|-
|[[STBT5:Haemangioma_of_bone|Haemangioma of bone]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|11/14/2025
|Katie Schieffer
|11/14/2025
|No genetic association
|-
|-
|[[STBT5:Sarcoma_with_BCOR_genetic_alterations|Sarcoma with BCOR genetic alterations]]
|[[STBT5:Epithelioid_haemangioma_of_bone|Epithelioid haemangioma of bone]]
|Disease
|Disease
|
|
Line 1,389: Line 1,873:
|
|
|-
|-
|CHAPTER 4 (BONE TUMOURS)
|[[STBT5:Epithelioid_haemangioendothelioma_of_bone|Epithelioid haemangioendothelioma of bone]]
|Disease
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
----
|-
|-
|[[STBT5:Subungual_exostosis|Subungual exostosis]]
|-
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[STBT5:Angiosarcoma_of_bone|Angiosarcoma of bone]]
|Disease
|Disease
|
|
Line 1,420: Line 1,904:
|
|
|-
|-
|[[STBT5:Bizarre_parosteal_osteochondromatous_proliferation|Bizarre parosteal osteochondromatous proliferation]]
|[[STBT5:Aneurysmal_bone_cyst|Aneurysmal bone cyst]]
|Disease
|Disease
|
|
Line 1,431: Line 1,915:
|
|
|-
|-
|[[STBT5:Periosteal_chondroma|Periosteal chondroma]]
|[[STBT5:Giant_cell_tumour_of_bone_|Giant cell tumour of bone]]
|Disease
|Disease
|
|
Line 1,442: Line 1,926:
|
|
|-
|-
|[[STBT5:Enchondroma|Enchondroma]]
|[[STBT5:Non-ossifying_fibroma|Non-ossifying fibroma]]
|Disease
|Disease
|
|
Line 1,453: Line 1,937:
|
|
|-
|-
|[[STBT5:Osteochondroma|Osteochondroma]]
|[[STBT5:Benign_notochordal_cell_tumour_|Benign notochordal cell tumour]]
|Disease
|Disease
|
|
Line 1,464: Line 1,948:
|
|
|-
|-
|[[STBT5:Chondroblastoma|Chondroblastoma]]
|[[STBT5:Conventional_chordoma|Conventional chordoma]]
|Disease
|Disease
|
|
Line 1,475: Line 1,959:
|
|
|-
|-
|[[STBT5:Chondromyxoid_fibroma|Chondromyxoid fibroma]]
|[[STBT5:Dedifferentiated_chordoma|Dedifferentiated chordoma]]
|Disease
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|11/14/2025
|Katie Schieffer
|11/14/2025
|No genetic association, early genetic studies referenced
|-
|[[STBT5:Poorly_differentiated_chordoma|Poorly differentiated chordoma]]
|Disease
|
|
|
|
|
Line 1,484: Line 1,980:
|
|
|
|
|
|-
|-
|[[STBT5:Osteochondromyxoma|Osteochondromyxoma]]
|[[STBT5:Chondromesenchymal_hamartoma_of_chest_wall|Chondromesenchymal hamartoma of chest wall]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|11/14/2025
|Katie Schieffer
|11/14/2025
|No genetic association
|-
|[[STBT5:Osteofibrous_dysplasia_|Osteofibrous dysplasia]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|10/22/2025
|Katie Schieffer
|10/22/2025
|
|-
|-
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[STBT5:Adamantinoma_of_long_bones|Adamantinoma of long bones]]
|Disease
|Disease
|
|
Line 1,497: Line 2,023:
|
|
|-
|-
|[[STBT5:Synovial_chondromatosis|Synovial chondromatosis]]
|[[STBT5:Simple_bone_cyst|Simple bone cyst]]
|Disease
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|10/21/2025
|Katie Schieffer
|10/21/2025
|
|
|
|-
|
|[[STBT5:Fibrocartilaginous_mesenchymoma|Fibrocartilaginous mesenchymoma]]
|
|Disease
|
|Katie Schieffer
|
|9/21/2025
|
|12/21/2025
|COMPLETE
|10/21/2025
|Katie Schieffer
|10/21/2025
|
|
|-
|-
|[[STBT5:Central_atypical_cartilaginous_tumour_/_chondrosarcoma,_grade_1|Central atypical cartilaginous tumour / chondrosarcoma, grade 1]]
|[[STBT5:Fibrous_dysplasia|Fibrous dysplasia]]
|Disease
|Disease
|
|
Line 1,519: Line 2,056:
|
|
|-
|-
|[[STBT5:Secondary_peripheral_atypical_cartilaginous_tumour_/_chondrosarcoma,_grade_1|Secondary peripheral atypical cartilaginous tumour / chondrosarcoma, grade 1]]
|[[STBT5:Lipoma_and_hibernoma_of_bone|Lipoma and hibernoma of bone]]
|Disease
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|PENDING
|
|
|
|
|
|
|Refer to lipoma and hibernoma pages in STBT book
|-
|[[STBT5:Leiomyosarcoma_of_bone|Leiomyosarcoma of bone]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|PENDING
|
|
|
|
|
|
|
|Refer to leiomyosarcoma page in STBT book
|
|-
|-
|[[STBT5:Central_chondrosarcoma,_grades_2_and_3|Central chondrosarcoma, grades 2 and 3]]
|[[STBT5:Undifferentiated_pleomorphic_sarcoma|Undifferentiated pleomorphic sarcoma]]
|Disease
|Disease
|
|
Line 1,541: Line 2,089:
|
|
|-
|-
|[[STBT5:Secondary_peripheral_chondrosarcoma,_grades_2_and_3|Secondary peripheral chondrosarcoma, grades 2 and 3]]
|[[STBT5:Bone_metastases|Bone metastases]]
|Disease
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|10/21/2025
|Katie Schieffer
|10/21/2025
|
|
|-
|[[STBT5:Solitary_plasmacytoma_of_bone|Solitary plasmacytoma of bone]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|PENDING
|
|
|
|
|
|
|
|Refer to plasmacytoma page in heme book
|
|
|
|-
|-
|[[STBT5:Periosteal_chondrosarcoma|Periosteal chondrosarcoma]]
|[[STBT5:Primary_non-Hodgkin_lymphoma_of_bone|Primary non-Hodgkin lymphoma of bone]]
|Disease
|Disease
|
|
Line 1,561: Line 2,120:
|
|
|
|
|
|Refer to heme book
|-
|-
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|-
|[[STBT5:Clear_cell_chondrosarcoma|Clear cell chondrosarcoma]]
|[[STBT5:Langerhans_cell_histiocytosis_|Langerhans cell histiocytosis]]
|Disease
|Disease
|
|
Line 1,572: Line 2,140:
|
|
|
|
|
|Refer to heme book
|-
|-
|[[STBT5:Mesenchymal_chondrosarcoma|Mesenchymal chondrosarcoma]]
|[[STBT5:Erdheim-Chester_disease_|Erdheim-Chester disease]]
|Disease
|Disease
|
|
Line 1,583: Line 2,151:
|
|
|
|
|
|Refer to heme book
|-
|-
|[[STBT5:Dedifferentiated_chondrosarcoma_|Dedifferentiated chondrosarcoma]]
|[[STBT5:Rosai-Dorfman_disease|Rosai-Dorfman disease]]
|Disease
|Disease
|
|
Line 1,594: Line 2,162:
|
|
|
|
|
|Refer to heme book
|-
|-
|[[STBT5:Osteoma|Osteoma]]
|Disease
|
|
|
|
====CHAPTER 5 (GENETIC TUMOUR SYNDROMES OF SOFT TISSUE AND BONE)====
|
|
|
|
|
|-
|[[STBT5:Osteoid_osteoma_|Osteoid osteoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Osteoblastoma_|Osteoblastoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Low-grade_central_osteosarcoma|Low-grade central osteosarcoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Osteosarcoma|Osteosarcoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Parosteal_osteosarcoma_|Parosteal osteosarcoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Periosteal_osteosarcoma_|Periosteal osteosarcoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:High-grade_surface_osteosarcoma|High-grade surface osteosarcoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Secondary_osteosarcoma|Secondary osteosarcoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Desmoplastic_fibroma_of_bone|Desmoplastic fibroma of bone]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Fibrosarcoma_of_bone|Fibrosarcoma of bone]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Haemangioma_of_bone|Haemangioma of bone]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Epithelioid_haemangioma_of_bone|Epithelioid haemangioma of bone]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Epithelioid_haemangioendothelioma_of_bone|Epithelioid haemangioendothelioma of bone]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Angiosarcoma_of_bone|Angiosarcoma of bone]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Aneurysmal_bone_cyst|Aneurysmal bone cyst]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Giant_cell_tumour_of_bone_|Giant cell tumour of bone]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Non-ossifying_fibroma|Non-ossifying fibroma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Benign_notochordal_cell_tumour_|Benign notochordal cell tumour]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Conventional_chordoma|Conventional chordoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Dedifferentiated_chordoma|Dedifferentiated chordoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Poorly_differentiated_chordoma|Poorly differentiated chordoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Chondromesenchymal_hamartoma_of_chest_wall|Chondromesenchymal hamartoma of chest wall]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Osteofibrous_dysplasia_|Osteofibrous dysplasia]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Adamantinoma_of_long_bones|Adamantinoma of long bones]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Simple_bone_cyst|Simple bone cyst]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Fibrocartilaginous_mesenchymoma|Fibrocartilaginous mesenchymoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Fibrous_dysplasia|Fibrous dysplasia]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Lipoma_and_hibernoma_of_bone|Lipoma and hibernoma of bone]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Leiomyosarcoma_of_bone|Leiomyosarcoma of bone]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Undifferentiated_pleomorphic_sarcoma|Undifferentiated pleomorphic sarcoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Bone_metastases|Bone metastases]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Solitary_plasmacytoma_of_bone|Solitary plasmacytoma of bone]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Primary_non-Hodgkin_lymphoma_of_bone|Primary non-Hodgkin lymphoma of bone]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Langerhans_cell_histiocytosis_|Langerhans cell histiocytosis]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Erdheim-Chester_disease_|Erdheim-Chester disease]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Rosai-Dorfman_disease|Rosai-Dorfman disease]]
|Disease
|
|
|
|
|
|
|
|
|-
|CHAPTER 5 (GENETIC TUMOUR SYNDROMES OF SOFT TISSUE AND BONE)
|
|
----
----

Latest revision as of 08:31, 20 January 2026

Welcome!

For assignments, please see the "Author" column below (highlighted blue).

If empty (no name is present), please volunteer to create content for that disease!

To volunteer, please [Contact us] with your page of interest.

WHO Classification of Soft Tissue and Bone Tumours (5th edition) Content
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes

CHAPTER 2 (SOFT TISSUE TUMOURS)
Lipoma Disease
Lipomatosis Disease
Lipomatosis of nerve Disease
Lipoblastoma and lipoblastomatosis Disease
Angiolipoma Disease
Myolipoma of soft tissue Disease
Chondroid lipoma Disease
Spindle cell lipoma and pleomorphic lipoma Disease
Hibernoma Disease
Atypical spindle cell / pleomorphic lipomatous tumour Disease
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Atypical lipomatous tumour / well-differentiated liposarcoma Disease
Dedifferentiated liposarcoma Disease
Myxoid liposarcoma Disease
Pleomorphic liposarcoma Disease
Myxoid pleomorphic liposarcoma Disease
Nodular fasciitis Disease
Proliferative fasciitis and proliferative myositis Disease Katie Schieffer 9/21/2025 12/21/2025 COMPLETE 12/8/2025 Katie Schieffer 12/8/2025 Minimal genetic content added
Myositis ossificans and fibro-osseous pseudotumour of digits Disease
Ischaemic fasciitis Disease Katie Schieffer 9/21/2025 12/21/2025 COMPLETE 10/16/2025 Katie Schieffer 10/16/2025 No genetic association
Elastofibroma Disease
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Fibrous hamartoma of infancy Disease
Fibromatosis colli Disease Katie Schieffer 9/21/2025 12/21/2025 COMPLETE 9/22/2025 Katie Schieffer 9/22/2025 No genetic association
Juvenile hyaline fibromatosis Disease
Inclusion body fibromatosis Disease Katie Schieffer 9/21/2025 12/21/2025 COMPLETE 10/16/2025 Katie Schieffer 10/16/2025 No genetic association
Fibroma of tendon sheath Disease
Desmoplastic fibroblastoma Disease
Myofibroblastoma Disease
Calcifying aponeurotic fibroma Disease
EWSR1-SMAD3-positive fibroblastic tumour (emerging) Disease
Angiomyofibroblastoma Disease Katie Schieffer 9/21/2025 12/21/2025 COMPLETE 10/21/2025 Katie Schieffer 10/21/2025
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Cellular angiofibroma Disease
Angiofibroma of soft tissue Disease
Nuchal-type fibroma Disease Katie Schieffer 9/21/2025 12/21/2025 COMPLETE 12/8/2025 Katie Schieffer 12/8/2025 No genetic association
Acral fibromyxoma Disease
Gardner fibroma Disease
Palmar fibromatosis and plantar fibromatosis Disease Kati

e Schieffer

9/21/2025 12/21/2025 COMPLETE 12/12/2025 Katie Schieffer 12/12/2025 Minimal genetic content added
Desmoid fibromatosis Disease
Lipofibromatosis Disease
Giant cell fibroblastoma Disease
Dermatofibrosarcoma protuberans Disease
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Solitary fibrous tumour Disease Yiting Li (trainee);

Shashirekha Shetty (mentor)

9/24/2025 12/24/2025 COMPLETE 12/18/2025 Katie Schieffer 12/18/2025
Inflammatory myofibroblastic tumour Disease
Low-grade myofibroblastic sarcoma Disease Katie Schieffer 9/21/2025 12/21/2025 COMPLETE 12/10/2025 Katie Schieffer 12/10/2025 No genetic association
Superficial CD34-positive fibroblastic tumour Disease
Myxoinflammatory fibroblastic sarcoma Disease Mokhtar Abdelhammed, MD (trainee);

Katie Schieffer (mentor)

3/1/2026 6/30/2026 PENDING
Infantile fibrosarcoma Disease Katie Schieffer 4/21/2025 10/1/2025 COMPLETE 9/18/2025 Katie Schieffer 9/18/2025
Adult fibrosarcoma Disease
Myxofibrosarcoma Disease
Low-grade fibromyxoid sarcoma Disease
Sclerosing epithelioid fibrosarcoma Disease
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Tenosynovial giant cell tumour Disease
Deep fibrous histiocytoma Disease
Plexiform fibrohistiocytic tumour Disease Katie Schieffer 9/21/2025 12/21/2025 COMPLETE 12/8/2025 Katie Schieffer 12/8/2025 No genetic association
Giant cell tumour of soft tissue Disease Katie Schieffer 9/21/2025 12/21/2025 COMPLETE 12/10/2025 Katie Schieffer 12/10/2025 No genetic association
Synovial haemangioma Disease Katie Schieffer 9/21/2025 12/21/2025 COMPLETE 11/10/2025 Katie Schieffer 11/10/2025 No genetic association
Intramuscular angioma Disease Katie Schieffer 9/21/2025 12/21/2025 COMPLETE 12/10/2025 Katie Schieffer 12/10/2025 No genetic association
Arteriovenous malformation/haemangioma Disease
Venous haemangioma Disease Katie Schieffer 9/21/2025 12/21/2025 COMPLETE 12/10/2025 Katie Schieffer 12/10/2025 No genetic association
Anastomosing haemangioma Disease
Epithelioid haemangioma Disease
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Lymphangioma and lymphangiomatosis Disease
Tufted angioma and kaposiform haemangioendothelioma Disease
Retiform haemangioendothelioma Disease Katie Schieffer 9/21/2025 12/21/2025 COMPLETE 12/11/2025 Katie Schieffer 12/11/2025 Minimal genetic content added
Papillary intralymphatic angioendothelioma Disease Katie Schieffer 9/21/2025 12/21/2025 COMPLETE 12/11/2025 Katie Schieffer 12/11/2025 Minimal genetic content added
Composite haemangioendothelioma Disease
Kaposi sarcoma Disease
Pseudomyogenic haemangioendothelioma Disease
Epithelioid haemangioendothelioma Disease
Angiosarcoma Disease
Glomus tumour Disease
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Myopericytoma, including myofibroma Disease
Angioleiomyoma Disease
Leiomyoma Disease
EBV-associated smooth muscle tumour Disease Katie Schieffer 9/21/2025 12/21/2025 COMPLETE 12/12/2025 Katie Schieffer 12/12/2025 No genetic association
Inflammatory leiomyosarcoma Disease
Leiomyosarcoma Disease
Rhabdomyoma Disease
Embryonal rhabdomyosarcoma Disease
Alveolar rhabdomyosarcoma Disease
Pleomorphic rhabdomyosarcoma Disease
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Spindle cell / sclerosing rhabdomyosarcoma Disease
Ectomesenchymoma Disease
Gastrointestinal stromal tumour Disease
Soft tissue chondroma Disease
Extraskeletal osteosarcoma Disease
Schwannoma Disease
Neurofibroma Disease
Perineurioma Disease
Granular cell tumour Disease
Dermal nerve sheath myxoma Disease Katie Schieffer 9/21/2025 12/21/2025 COMPLETE 12/11/2025 Katie Schieffer 12/11/2025 No genetic association
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Solitary circumscribed neuroma Disease Katie Schieffer 9/21/2025 12/21/2025 COMPLETE 12/11/2025 Katie Schieffer 12/11/2025 No genetic association
Ectopic meningioma and meningothelial hamartoma Disease Katie Schieffer 9/21/2025 12/21/2025 PENDING Consider linking to CNS tumor book
Benign triton tumour / neuromuscular choristoma Disease
Hybrid nerve sheath tumour Disease
Malignant peripheral nerve sheath tumour Disease
Malignant melanotic nerve sheath tumour Disease
Intramuscular myxoma Disease
Juxta-articular myxoma Disease Katie Schieffer 9/21/2025 12/21/2025 COMPLETE 12/12/2025 Katie Schieffer 12/12/2025 No genetic association
Deep (aggressive) angiomyxoma Disease
Atypical fibroxanthoma Disease
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Angiomatoid fibrous histiocytoma Disease
Ossifying fibromyxoid tumour Disease
Myoepithelioma, myoepithelial carcinoma, and mixed tumour Disease
Pleomorphic hyalinizing angiectatic tumour of soft parts Disease Mokhtar Abdelhammed, MD (trainee);

Katie Schieffer (mentor)

9/11/2025 12/11/2025 COMPLETE 12/29/2026 Katie Schieffer 1/7/2026
Haemosiderotic fibrolipomatous tumour Disease Mokhtar Abdelhammed, MD (trainee);

Katie Schieffer (mentor)

3/1/2026 6/30/2026 PENDING
Phosphaturic mesenchymal tumour Disease
NTRK-rearranged spindle cell neoplasm (emerging) Disease James Solomon, MD, PhD 2/20/2022 12/9/2025 PENDING Katie Schieffer
Synovial sarcoma Disease
Epithelioid sarcoma Disease
Alveolar soft part sarcoma Disease Maxine Sutcliffe, PhD 10/13/2025 12/31/2025 COMPLETE 12/24/2025 Katie Schieffer 12/24/2025
Clear cell sarcoma of soft tissue Disease
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Extraskeletal myxoid chondrosarcoma Disease
Desmoplastic small round cell tumour Disease Maxine Sutcliffe, PhD 1/12/2026 4/12/2026 PENDING
Extrarenal rhabdoid tumour Disease
PEComa Disease
Intimal sarcoma Disease
Undifferentiated sarcoma Disease

CHAPTER 3 (UNDIFFERENTIATED SMALL ROUND CELL SARCOMAS OF BONE AND SOFT TISSUE)
Ewing sarcoma Disease Sadeem Qdaisat (trainee); Eric McGinnis (mentor) 10/1/2023 12/9/2025 PENDING Katie Schieffer
Round cell sarcoma with EWSR1-non-ETS fusions Disease
CIC-rearranged sarcoma Disease
Sarcoma with BCOR genetic alterations Disease
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes

CHAPTER 4 (BONE TUMOURS)
Subungual exostosis Disease Katie Schieffer 9/21/2025 12/21/2025 COMPLETE 12/12/2025 Katie Schieffer 12/12/2025 No genetic association
Bizarre parosteal osteochondromatous proliferation Disease Katie Schieffer 9/21/2025 12/21/2025 COMPLETE 12/8/2025 Katie Schieffer 12/8/2025
Periosteal chondroma Disease Katie Schieffer 9/21/2025 12/21/2025 PENDING
Enchondroma Disease Katie Schieffer 9/21/2025 12/21/2025 PENDING
Osteochondroma Disease Katie Schieffer 9/21/2025 12/21/2025 PENDING
Chondroblastoma Disease Katie Schieffer 9/21/2025 12/21/2025 COMPLETE 11/14/2025 Katie Schieffer 11/14/2025
Chondromyxoid fibroma Disease
Osteochondromyxoma Disease
Synovial chondromatosis Disease
Central atypical cartilaginous tumour / chondrosarcoma, grade 1 Disease Katie Schieffer 9/21/2025 12/31/2025 COMPLETE 11/14/2025 Katie Schieffer 11/14/2025
Secondary peripheral atypical cartilaginous tumour / chondrosarcoma, grade 1 Disease
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Central chondrosarcoma, grades 2 and 3 Disease
Secondary peripheral chondrosarcoma, grades 2 and 3 Disease
Periosteal chondrosarcoma Disease
Clear cell chondrosarcoma Disease
Mesenchymal chondrosarcoma Disease
Dedifferentiated chondrosarcoma Disease
Osteoma Disease
Osteoid osteoma Disease
Osteoblastoma Disease
Low-grade central osteosarcoma Disease
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Osteosarcoma Disease Fang Fang (trainee); Katie Schieffer (mentor) 11/19/2025 2/15/2026 PENDING Katie Schieffer
Parosteal osteosarcoma Disease
Periosteal osteosarcoma Disease
High-grade surface osteosarcoma Disease
Secondary osteosarcoma Disease
Desmoplastic fibroma of bone Disease
Fibrosarcoma of bone Disease
Haemangioma of bone Disease Katie Schieffer 9/21/2025 12/21/2025 COMPLETE 11/14/2025 Katie Schieffer 11/14/2025 No genetic association
Epithelioid haemangioma of bone Disease
Epithelioid haemangioendothelioma of bone Disease
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Angiosarcoma of bone Disease
Aneurysmal bone cyst Disease
Giant cell tumour of bone Disease
Non-ossifying fibroma Disease
Benign notochordal cell tumour Disease
Conventional chordoma Disease
Dedifferentiated chordoma Disease Katie Schieffer 9/21/2025 12/21/2025 COMPLETE 11/14/2025 Katie Schieffer 11/14/2025 No genetic association, early genetic studies referenced
Poorly differentiated chordoma Disease
Chondromesenchymal hamartoma of chest wall Disease Katie Schieffer 9/21/2025 12/21/2025 COMPLETE 11/14/2025 Katie Schieffer 11/14/2025 No genetic association
Osteofibrous dysplasia Disease Katie Schieffer 9/21/2025 12/21/2025 COMPLETE 10/22/2025 Katie Schieffer 10/22/2025
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Adamantinoma of long bones Disease
Simple bone cyst Disease Katie Schieffer 9/21/2025 12/21/2025 COMPLETE 10/21/2025 Katie Schieffer 10/21/2025
Fibrocartilaginous mesenchymoma Disease Katie Schieffer 9/21/2025 12/21/2025 COMPLETE 10/21/2025 Katie Schieffer 10/21/2025
Fibrous dysplasia Disease
Lipoma and hibernoma of bone Disease Katie Schieffer 9/21/2025 12/21/2025 PENDING Refer to lipoma and hibernoma pages in STBT book
Leiomyosarcoma of bone Disease Katie Schieffer 9/21/2025 12/21/2025 PENDING Refer to leiomyosarcoma page in STBT book
Undifferentiated pleomorphic sarcoma Disease
Bone metastases Disease Katie Schieffer 9/21/2025 12/21/2025 COMPLETE 10/21/2025 Katie Schieffer 10/21/2025
Solitary plasmacytoma of bone Disease Katie Schieffer 9/21/2025 12/21/2025 PENDING Refer to plasmacytoma page in heme book
Primary non-Hodgkin lymphoma of bone Disease Refer to heme book
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Langerhans cell histiocytosis Disease Refer to heme book
Erdheim-Chester disease Disease Refer to heme book
Rosai-Dorfman disease Disease Refer to heme book

CHAPTER 5 (GENETIC TUMOUR SYNDROMES OF SOFT TISSUE AND BONE)
Enchondromatosis Disease
Li-Fraumeni syndrome Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A N/A
McCune-Albright syndrome Disease
Multiple osteochondromas Disease
Neurofibromatosis type 1 Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A N/A
Rothmund-Thomson syndrome Disease
Werner syndrome Disease


Retrieved from "https://test.ccga.io/index.php?title=STBT5:Volunteer_Assignments_and_Opportunities&oldid=20107"